Health & Fitness

According to FutureWise analysis, the connected healthcare market in 2025 is US$147.92 billion, and is expected to reach US$640.34 billion by 2033 at a CAGR of 29.01%. The connected healthcare market is experiencing significant and dynamic growth, driven by the seamless integration of artificial intelligence (AI), advanced telemedicine platforms, and innovative real-time health monitoring technologies. This robust expansion can be attributed to several key factors, most notably the escalating demand for remote care solutions. These solutions enable patients to receive medical attention from the comfort and safety of their own homes, which has become increasingly vital, especially in the wake of global health crises that emphasize the need for distance in healthcare delivery. As populations age—particularly in regions with rising life expectancies—there exists a heightened demand for consistent and comprehensive health management. This is especially true for ... Continue reading →

According to FutureWise analysis, the connected medical devices market in 2025 is US$82.24 billion, and is expected to reach US$390.36 billion by 2033 at a CAGR of 21.49%. Connected medical devices refer to medical equipment that interfaces with data-collection and monitoring platforms, such as computers and smartphones, to streamline the management of patient health information. These devices play a pivotal role in helping caregivers and healthcare professionals accurately document patient data for ongoing monitoring, follow-ups, and consultations. By leveraging this data, healthcare providers can make informed decisions that potentially lead to improved patient outcomes. The surge in healthcare sector growth can primarily be attributed to the increasing adoption of Internet of Medical Things (IoMT) technologies and a rising demand for remote patient monitoring solutions. IoMT includes a wide range of connected devices that facilitate the exchange of health-related data ... Continue reading →

According to FutureWise analysis, the CRISPR and Cas genes market in 2025 is US$4.79 billion, and is expected to reach US$16.73 billion by 2033 at a CAGR of 16.92%. The CRISPR and Cas genes market is currently experiencing significant growth, largely driven by groundbreaking advances in gene therapy applications and a notable increase in investments in precision medicine research. This innovative technology stands out for its potential to revolutionize various sectors, particularly in agricultural biotechnology. Here, CRISPR is used to develop genetically modified crops with enhanced resistance to pests and environmental stressors, addressing critical issues such as food security and sustainability in the face of climate change. In addition to agricultural applications, CRISPR technology is making substantial inroads into drug discovery. By facilitating the identification and validation of new drug targets, CRISPR is accelerating the development of novel treatments for a broad ... Continue reading →

According to FutureWise analysis, the dental 3D printing market in 2025 is US$4.08 billion, and is expected to reach US$20.91 billion by 2033 at a CAGR of 22.66%.  dental 3D printing market is currently experiencing significant growth, fueled by the increasing demand for personalized dental solutions and the rising adoption of digital dentistry workflows. This innovative technology offers the advantages of reduced production time and costs, while also enhancing precision. As a result, it is gaining widespread acceptance among dental laboratories and clinics. Additionally, advancements in biocompatible materials and multi-material printing are expanding its applications in key areas such as orthodontics, prosthodontics, and implantology. Dental 3D printing involves producing three-dimensional dental models or prosthetics from a digital 3D model. The field of dentistry is witnessing a surge in the adoption of advanced technologies due to their numerous benefits over ... Continue reading →

According to FutureWise analysis, the Dental 3D Printing Materials market in 2025 is US$2.47 billion, and is expected to reach US$10.52 billion by 2033 at a CAGR of 19.86%. Dental 3D Printing Materials market is experiencing remarkable growth, driven primarily by innovations in advanced biocompatible resins that cater to the evolving needs of dental professionals and their patients. This expansion can be attributed to the rising demand for high-performance printing materials that not only meet stringent clinical requirements but also optimize aesthetic outcomes. Recent technological advancements have enabled the formulation of novel materials with enhanced mechanical properties, including increased strength, flexibility, and durability, which are essential for diverse dental applications. These improvements are pivotal in broadening the scope of clinical applications for dental 3D printing, allowing practitioners to offer innovative solutions such as customized prosthetics, ... Continue reading →

According to FutureWise analysis, the dermatology treatment devices market in 2025 is US$8.35 billion, and is expected to reach US$25.14 billion by 2033 at a CAGR of 14.77%. Dermatology is a medical specialty focused on disorders that affect the skin. In addition to the skin, it also encompasses issues related to nails, hair, and the delicate linings of the eyelids, nose, and mouth. The skin, being the body's largest organ, consists of various components such as nerve endings, sweat glands, hair follicles, pores, and blood vessels. Dermatology utilizes specialized equipment to diagnose and treat skin problems. Some available procedures include skin biopsies, cryosurgery, topical chemotherapy, photodynamic therapy, Mohs micrographic surgery, and electrodessication-curettage. Common skin disorders include psoriasis, eczema, acne, rosacea, ichthyosis, vitiligo, hives, and seborrheic dermatitis. The significant growth in the dermatology sector can be attributed to several ... Continue reading →

According to FutureWise analysis the market for clear aligners in 2025 is US$ 8.74 billion, and is expected to reach US$ 52.19 billion by 2033 at a CAGR of 25.03%. The market is rapidly growing due to rising demand for aesthetic and comfortable orthodontic solutions, especially among adults and teens. Key factors include greater awareness of dental health, advances in 3D printing and AI treatment planning, and a preference for at-home aligner kits. Clear aligners, much like traditional braces, are transparent trays designed to align teeth effectively. These aligners apply gentle, consistent pressure to move teeth into their desired positions, eliminating the discomfort of metal wires and brackets commonly associated with braces. Each set of aligners is custom-made for the patient, utilizing computer scans to design a precise treatment plan. The process involves taking a digital impression of the teeth, analyzing the data with specialized software, and using a milling machine to ... Continue reading →

According to FutureWise analysis the market for biopharmaceutical logistics in 2023 is US$ 82.30 billion, and is expected to reach US$ 149.20 billion by 2031 at a CAGR of 7.72%. Biopharmaceutical logistics is a critical sector focused on the safe and effective transportation of life-saving therapies, such as vaccines, monoclonal antibodies, cell and gene therapies, and temperature-sensitive biologics. This field is vital because it ensures that these products reach patients without losing their potency, purity, or safety. Unlike traditional freight logistics, biopharmaceutical logistics operates under high-pressure conditions, facing challenges related to molecular degradation, regulatory compliance, and the complexities of global supply chains. The process of biopharmaceutical logistics involves four main components. Cold-Chain Management: A significant portion of biopharma products—approximately 70%—requires specific temperature controls, typically between 2–8 ... Continue reading →

Biopharmaceutical oral drug delivery is emerging as a groundbreaking approach in modern medicine, focusing on the administration of biologically derived drugs—such as proteins, peptides, nucleic acids, and monoclonal antibodies—via the oral route. Traditionally, these biologics have required injection due to challenges related to their large molecular size, poor stability, and limited absorption in the gastrointestinal (GI) tract. The shift to oral delivery is gaining momentum, as it offers numerous benefits including improved patient adherence, simplified administration, and lower healthcare costs, making it an increasingly preferred method for delivering biopharmaceuticals. However, the development of effective oral formulations faces significant challenges primarily stemming from physiological barriers. These include enzymatic degradation, limited permeability of intestinal epithelial cells, and fluctuations in pH throughout the GI tract. To combat these issues, ... Continue reading →

According to FutureWise analysis the market for biopharmaceutical processing equipment and consumables is expected to reach US$ 86.53 billion by 2031 at a CAGR of 10.50%. Biopharmaceutical processing encompasses the comprehensive study of the discovery, development, and manufacturing of complex medicines that are derived from living organisms and biological systems. This sector plays a critical role in the healthcare landscape, producing a diverse range of biopharmaceuticals, including vaccines, whole blood and its components, gene therapies, recombinant therapeutic proteins, and somatic cells. The biopharmaceutical industry relies on a variety of advanced technologies and equipment to ensure efficient and safe production. Key components of this infrastructure include sophisticated filtration systems that enhance the purity of products, chromatography systems for effective separation and analysis, bioreactors that provide controlled environments for cell growth, and cell culture ... Continue reading →